Catalytic dechlorination of diclofenac by biogenic palladium in a microbial electrolysis cell

Abstract

Diclofenac is one of the most commonly detected pharmaceuticals in wastewater treatment plant (WWTP) effluents and the receiving water bodies. In this study, biogenic Pd nanoparticles ('bio-Pd') were successfully applied in a microbial electrolysis cell (MEC) for the catalytic reduction of diclofenac. Hydrogen gas was produced in the cathodic compartment, and consumed as a hydrogen donor by the bio-Pd on the graphite electrodes. In this way, complete dechlorination of 1mgdiclofenacl-1 was achieved during batch recirculation experiments, whereas no significant removal was observed in the absence of the biocatalyst. The complete dechlorination of diclofenac was demonstrated by the concomitant production of 2-anilinophenylacetate (APA). Through the addition of -0.8V to the circuit, continuous and complete removal of diclofenac was achieved in synthetic medium at a minimal HRT of 2h. Continuous treatment of hospital WWTP effluent containing 1.28μgdiclofenacl-1 resulted in a lower removal efficiency of 57%, which can probably be attributed to the affinity of other environmental constituents for the bio-Pd catalyst. Nevertheless, reductive catalysis coupled to sustainable hydrogen production in a MEC offers potential to lower the release of micropollutants from point-sources such as hospital WWTPs. © 2012 The Authors. Microbial Biotechnology © 2012 Society for Applied Microbiology and Blackwell Publishing Ltd.